105 related articles for article (PubMed ID: 27155522)
21. MicroRNA-10a is reduced in breast cancer and regulated in part through retinoic acid.
Khan S; Wall D; Curran C; Newell J; Kerin MJ; Dwyer RM
BMC Cancer; 2015 May; 15():345. PubMed ID: 25934412
[TBL] [Abstract][Full Text] [Related]
22. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.
Jalava SE; Urbanucci A; Latonen L; Waltering KK; Sahu B; Jänne OA; Seppälä J; Lähdesmäki H; Tammela TL; Visakorpi T
Oncogene; 2012 Oct; 31(41):4460-71. PubMed ID: 22266859
[TBL] [Abstract][Full Text] [Related]
23. Structural organization and expression of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin II AT2 receptor-interacting proteins, ATIP.
Di Benedetto M; Bièche I; Deshayes F; Vacher S; Nouet S; Collura V; Seitz I; Louis S; Pineau P; Amsellem-Ouazana D; Couraud PO; Strosberg AD; Stoppa-Lyonnet D; Lidereau R; Nahmias C
Gene; 2006 Oct; 380(2):127-36. PubMed ID: 16887298
[TBL] [Abstract][Full Text] [Related]
24. The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer.
Gravgaard KH; Lyng MB; Laenkholm AV; Søkilde R; Nielsen BS; Litman T; Ditzel HJ
Breast Cancer Res Treat; 2012 Jul; 134(1):207-17. PubMed ID: 22294488
[TBL] [Abstract][Full Text] [Related]
25. [Dectection and analysis of miRNA expression in breast cancer-associated fibroblasts].
Zeng Z; Hu P; Tang X; Zhang H; Du Y; Wen S; Liu M
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1071-5. PubMed ID: 25270211
[TBL] [Abstract][Full Text] [Related]
26. A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells.
Leotta M; Biamonte L; Raimondi L; Ronchetti D; Di Martino MT; Botta C; Leone E; Pitari MR; Neri A; Giordano A; Tagliaferri P; Tassone P; Amodio N
J Cell Physiol; 2014 Dec; 229(12):2106-16. PubMed ID: 24819167
[TBL] [Abstract][Full Text] [Related]
27. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
[TBL] [Abstract][Full Text] [Related]
28. MiR-371-5p facilitates pancreatic cancer cell proliferation and decreases patient survival.
He D; Miao H; Xu Y; Xiong L; Wang Y; Xiang H; Zhang H; Zhang Z
PLoS One; 2014; 9(11):e112930. PubMed ID: 25411783
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer.
Aydoğdu E; Katchy A; Tsouko E; Lin CY; Haldosén LA; Helguero L; Williams C
Carcinogenesis; 2012 Aug; 33(8):1502-11. PubMed ID: 22562546
[TBL] [Abstract][Full Text] [Related]
30. The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.
Li H; Xie S; Liu M; Chen Z; Liu X; Wang L; Li D; Zhou Y
Int J Oncol; 2014 Jul; 45(1):197-208. PubMed ID: 24805774
[TBL] [Abstract][Full Text] [Related]
31. MicroRNAome in decidua: a new approach to assess the maintenance of pregnancy.
Wang Y; Lv Y; Wang L; Gong C; Sun J; Chen X; Chen Y; Yang L; Zhang Y; Yang X; Bai C; Wei Z; Li G
Fertil Steril; 2015 Apr; 103(4):980-989.e6. PubMed ID: 25747134
[TBL] [Abstract][Full Text] [Related]
32. MiRNA expression analysis of cancer-associated fibroblasts and normal fibroblasts in breast cancer.
Zhao L; Sun Y; Hou Y; Peng Q; Wang L; Luo H; Tang X; Zeng Z; Liu M
Int J Biochem Cell Biol; 2012 Nov; 44(11):2051-9. PubMed ID: 22964023
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-296-5p (miR-296-5p) functions as a tumor suppressor in prostate cancer by directly targeting Pin1.
Lee KH; Lin FC; Hsu TI; Lin JT; Guo JH; Tsai CH; Lee YC; Lee YC; Chen CL; Hsiao M; Lu PJ
Biochim Biophys Acta; 2014 Sep; 1843(9):2055-66. PubMed ID: 24915000
[TBL] [Abstract][Full Text] [Related]
34. miR-140-3p is a potential differential biomarker in benign phyllodes tumors and fibroadenoma of the breast.
Li Q; Liu Y; Bai J; Zhao S; Wang Y; Shabbir A; Zhang K; Jiang F; Zhu J; Ma R; Wang J
BMC Womens Health; 2022 Feb; 22(1):31. PubMed ID: 35120526
[TBL] [Abstract][Full Text] [Related]
35. Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA.
Hossain A; Kuo MT; Saunders GF
Mol Cell Biol; 2006 Nov; 26(21):8191-201. PubMed ID: 16940181
[TBL] [Abstract][Full Text] [Related]
36. MTUS1, a gene encoding angiotensin-II type 2 (AT2) receptor-interacting proteins, in health and disease, with special emphasis on its role in carcinogenesis.
Bozgeyik I; Yumrutas O; Bozgeyik E
Gene; 2017 Aug; 626():54-63. PubMed ID: 28499941
[TBL] [Abstract][Full Text] [Related]
37. miR-379 regulates cyclin B1 expression and is decreased in breast cancer.
Khan S; Brougham CL; Ryan J; Sahrudin A; O'Neill G; Wall D; Curran C; Newell J; Kerin MJ; Dwyer RM
PLoS One; 2013; 8(7):e68753. PubMed ID: 23874748
[TBL] [Abstract][Full Text] [Related]
38. 8p22 MTUS1 gene product ATIP3 is a novel anti-mitotic protein underexpressed in invasive breast carcinoma of poor prognosis.
Rodrigues-Ferreira S; Di Tommaso A; Dimitrov A; Cazaubon S; Gruel N; Colasson H; Nicolas A; Chaverot N; Molinié V; Reyal F; Sigal-Zafrani B; Terris B; Delattre O; Radvanyi F; Perez F; Vincent-Salomon A; Nahmias C
PLoS One; 2009 Oct; 4(10):e7239. PubMed ID: 19794912
[TBL] [Abstract][Full Text] [Related]
39. RNA-binding protein SORBS2 suppresses clear cell renal cell carcinoma metastasis by enhancing MTUS1 mRNA stability.
Lv Q; Dong F; Zhou Y; Cai Z; Wang G
Cell Death Dis; 2020 Dec; 11(12):1056. PubMed ID: 33311452
[TBL] [Abstract][Full Text] [Related]
40. Combinatorial expression of microtubule-associated EB1 and ATIP3 biomarkers improves breast cancer prognosis.
Rodrigues-Ferreira S; Nehlig A; Monchecourt C; Nasr S; Fuhrmann L; Lacroix-Triki M; Garberis I; Scott V; Delaloge S; Pistilli B; Vielh P; Dubois T; Vincent-Salomon A; André F; Nahmias C
Breast Cancer Res Treat; 2019 Feb; 173(3):573-583. PubMed ID: 30368744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
